Showing 8801-8810 of 23044 results for "".
Endoscopic Vein-Graft Harvesting in CABG Procedures
https://reachmd.com/programs/heart-matters/endoscopic-vein-graft-harvesting-in-cabg-procedures/4789/One of the reported benefits of endoscopic vein harvesting is a lower risk of wound complications following coronary bypass grafting, though it has yet to be established that long-term clinical outcomes for this technique are superior to those achieved using open harvesting under direct vision. NewLipid Lowering: The End or the Means to Better CV Results?
https://reachmd.com/programs/lipid-luminations/lipid-lowering-the-end-or-the-means-to-better-cv-results/4359/The answer almost assuredly is patient-specific, but the question of lipid-lowering as the end or the means in measuring cardiovascular risk highlights the ongoing discussion in medicine about targets: whether how we get there is more important than just getting there. Dr. Roger Blumenthal, professoDevelopments in Surgical Therapies for Valve Disease
https://reachmd.com/programs/heart-matters/developments-in-surgical-therapies-for-valve-disease/3903/Artificial heart valves have steadily evolved since their arrival on the surgical scene in the 1960s. A range of the newest devices have shown significant potential, including the prospect of valve replacement in high-risk, symptomatic patients with severe aortic stenosis. What are the most promisinStudy Shows Uncertainty in Role of Statins in Primary Prevention For Women
https://reachmd.com/programs/clinicians-roundtable/study-shows-uncertainty-in-role-of-statins-in-primary-prevention-for-women/3900/According to the results of a recent study, the use of statins for primary prevention in women is not supported by clinical-trial data. Theodore Eisenberg, a law professor at Cornell University, discusses the scope of the meta-analyses of the primary prevention clinical statin trial, and the conclusHelping Patients Deal with the Psychosocial Issues of Huntington's Disease
https://reachmd.com/programs/clinicians-roundtable/helping-patients-deal-with-the-psychosocial-issues-of-huntingtons-disease/3074/Dr. Robert Klitzman, associate professor of clinical psychology at Columbia University, discusses how to prepare patients and their families to deal with the complex issues that arise in families that have inherited Huntington's disease. Join host Dr. Maurice Pickard for this important discussion.Incorporating Spirituality into Medical Practice
https://reachmd.com/programs/clinicians-roundtable/incorporating-spirituality-into-medical-practice/2786/How can we address the formless notion of spirituality in the exam room? Moving beyond religion, Dr. Christina Puchalski, internist, and Director of the George Washington Institute for Spirituality in Health, and Associate Professor of Medicine and Health Sciences at George Washington University speCurrent Inquiries in Lipidology: The NLA's Role in the Field
https://reachmd.com/programs/lipid-luminations/current-inquiries-in-lipidology-the-nlas-role-in-the-field/6297/From reversing atherosclerosis with HDL modification to promising antibodies on the horizon for lowering LDL cholesterol, the science of lipidology is a quickly-evolving field. What is the role of the National Lipid Association in clinical practice for clinicians who may not be lipid specialists? HUpdating Guidelines for ST-Elevation MI
https://reachmd.com/programs/heart-matters/updating-guidelines-for-st-elevation-mi/3803/Revising treatment guidelines is a continuous process, with authors always monitoring the latest data that needs to be shared with practitioners. What developments prompted the latest updates to the guidelines for care of patients with acute myocardial infarction? Host Dr. Janet Wright visits with DPharma and Biotech Industries Pursue Treatments for Cardiac Inflammation
https://reachmd.com/programs/clinicians-roundtable/pharma-and-biotech-industries-pursue-treatments-for-cardiac-inflammation/3660/A treatment for atherosclerosis and the chronic inflammation in arterial blood vessels could be entering critical clinical trial stages that may result in a novel new treatment. Dr. Lawrence Cohen, president and chief executive officer of VIA Pharmaceuticals lays out for host ChiManaging Insulin-Resistant Patients With Multiple Risk Factors
https://reachmd.com/programs/lipid-luminations/managing-insulin-resistant-patients-with-multiple-risk-factors/3323/Host Dr. Larry Kaskel welcomes Dr. Yehuda Handelsman, medical director of the Metabolic Institute of America and chair of the International Committee for Insulin Resistance. Dr. Handelsman examines the relationship of insulin resistance to metabolic syndrome, as well as a series of clinical conditio